397 related articles for article (PubMed ID: 12542900)
21. Metabolism of theophylline and its inhibition by fluoroquinolones in rat hepatic microsomes.
Davis JD; Aarons L; Houston JB
Xenobiotica; 1995 Jun; 25(6):563-73. PubMed ID: 7483657
[TBL] [Abstract][Full Text] [Related]
22. Time-dependent effects of Klebsiella pneumoniae endotoxin on the pharmacokinetics of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, in rats: restoration of the parameters in 96 hour in KPLPS rats to control levels.
Jung HY; Kang HE; Choi YH; Kim SH; Lee MG
Biopharm Drug Dispos; 2009 Nov; 30(8):485-93. PubMed ID: 19753555
[TBL] [Abstract][Full Text] [Related]
23. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.
Ueng YF; Tsai TH; Don MJ; Chen RM; Chen TL
J Pharm Pharmacol; 2005 Feb; 57(2):227-32. PubMed ID: 15720787
[TBL] [Abstract][Full Text] [Related]
24. Effects of glucose supplementation on the pharmacokinetics of intravenous chlorzoxazone in rats with water deprivation for 72 h.
Kim YC; Lee I; Kim SG; Ko SH; Lee MG; Kim SH
Life Sci; 2006 Nov; 79(23):2179-86. PubMed ID: 16914164
[TBL] [Abstract][Full Text] [Related]
25. Effects of neostigmine on the pharmacokinetics of intravenous parathion in rats.
Hurh E; Lee EJ; Kim YG; Kim SY; Kim SH; Kim YC; Lee MG
Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):261-73. PubMed ID: 11913717
[TBL] [Abstract][Full Text] [Related]
26. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
[TBL] [Abstract][Full Text] [Related]
27. Altered intravenous pharmacokinetics of topotecan in rats with acute renal failure (ARF) induced by uranyl nitrate: do adenosine A1 antagonists (selective/non-selective) normalize the altered topotecan kinetics in ARF?
Mustafa S; Venkatesh P; Pasha K; Mullangi R; Srinivas NR
Xenobiotica; 2006 Dec; 36(12):1239-58. PubMed ID: 17162470
[TBL] [Abstract][Full Text] [Related]
28. Effects of recombinant human growth hormone on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate.
Chung W; Kim EJ; Lee I; Kim SG; Lee MG; Kim SH
Life Sci; 2003 Jun; 73(3):253-63. PubMed ID: 12757833
[TBL] [Abstract][Full Text] [Related]
29. Effect of decursinol angelate on the pharmacokinetics of theophylline and its metabolites in rats.
Chae JW; An JH; Kang W; Ma Jy; Kwon KI
Food Chem Toxicol; 2012 Oct; 50(10):3666-72. PubMed ID: 22771369
[TBL] [Abstract][Full Text] [Related]
30. Drug-drug interactions affecting fluoroquinolones.
Wijnands GJ; Vree TB; Janssen TJ; Guelen PJ
Am J Med; 1989 Dec; 87(6C):47S-51S. PubMed ID: 2603893
[TBL] [Abstract][Full Text] [Related]
31. Effects of acute renal failure on the pharmacokinetics of chlorzoxazone in rats.
Moon YJ; Lee AK; Chung HC; Kim EJ; Kim SH; Lee DC; Lee I; Kim SG; Lee MG
Drug Metab Dispos; 2003 Jun; 31(6):776-84. PubMed ID: 12756212
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.
Ahn CY; Bae SK; Jung YS; Lee I; Kim YC; Lee MG; Shin WG
Drug Metab Dispos; 2008 Jul; 36(7):1233-41. PubMed ID: 18378564
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats.
Ramzan IM; Levy G
J Pharmacol Exp Ther; 1986 Mar; 236(3):708-13. PubMed ID: 3485196
[TBL] [Abstract][Full Text] [Related]
34. Effect of experimental renal failure on the disposition kinetics of l-propranolol in rats.
Terao N; Shen DD
J Pharmacol Exp Ther; 1983 Nov; 227(2):295-301. PubMed ID: 6631714
[TBL] [Abstract][Full Text] [Related]
35. Biotransformation of theophylline in cirrhotic rats induced by biliary obstruction.
Park EJ; Ko G; Kim J; Sohn DH
Arch Pharm Res; 1999 Feb; 22(1):60-7. PubMed ID: 10071961
[TBL] [Abstract][Full Text] [Related]
36. Effects of water deprivation for 72 h on the pharmacokinetics of ipriflavone in rats.
Chung HJ; Lee I; Lee MG
Res Vet Sci; 2008 Aug; 85(1):149-55. PubMed ID: 17919668
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic changes of drugs in rat model of acute renal failure induced by uranyl nitrate: correlation between drug metabolism and hepatic microsomal cytochrome P450 isozymes.
Lee MG; Lee JH; Oh JM
Curr Clin Pharmacol; 2006 May; 1(2):193-205. PubMed ID: 18666371
[TBL] [Abstract][Full Text] [Related]
38. Effect of a new chemoprotective agent, 2-(allylthio)pyrazine, on the pharmacokinetics of intravenous theophylline in rats.
Han KS; Lee MG
Int J Pharm; 1999 Jul; 184(2):237-42. PubMed ID: 10387953
[TBL] [Abstract][Full Text] [Related]
39. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of 2-(allylthio) pyrazine, a chemoprotective agent, in rats: the role of CYP3A23 induction.
Lee EJ; Kim EJ; Kim YG; Chung HC; Kim SH; Kim DH; Lees I; Kim SG; Lee MG
Res Commun Mol Pathol Pharmacol; 2004; 115-116():111-21. PubMed ID: 17564310
[TBL] [Abstract][Full Text] [Related]
40. Reduced clearance of ε-acetamidocaproic acid in rats with acute renal failure induced by uranyl nitrate.
Han SY; Yang SH; Yoon I; Lee MG; Choi YH
J Pharm Pharmacol; 2012 Oct; 64(10):1452-60. PubMed ID: 22943176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
